By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Complete Genomics today priced its initial public offering at $9 per share, below the $12 to $14 range the company had earlier projected.

The shares are expected to begin trading on the Nasdaq Global Market today under ticker symbol "GNOM."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.